Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Kim, Tae Hyun, Park, Joong-Won, Kim, Bo Hyun, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Woo, Sang Myung, Koh, Young-Hwan, Lee, Woo Jin, Kim, Dae Yong
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7198869/
https://ncbi.nlm.nih.gov/pubmed/32411594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00542
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires